BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 26043385)

  • 1. Cold agglutinin-mediated autoimmune hemolytic anemia.
    Berentsen S; Randen U; Tjønnfjord GE
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.
    Berentsen S
    Front Immunol; 2020; 11():590. PubMed ID: 32318071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold agglutinin disease: where do we stand, and where are we going?
    Berentsen S; Malecka A; Randen U; Tjønnfjord GE
    Clin Adv Hematol Oncol; 2020 Jan; 18(1):35-44. PubMed ID: 32511221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold agglutinin disease.
    Berentsen S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):226-231. PubMed ID: 27913484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
    Berentsen S; Tjønnfjord GE
    Blood Rev; 2012 May; 26(3):107-15. PubMed ID: 22330255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of erythrocyte destruction in autoimmune hemolytic anemia].
    Yatomi Y
    Nihon Rinsho; 1996 Sep; 54(9):2397-401. PubMed ID: 8890568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement inhibitors to treat IgM-mediated autoimmune hemolysis.
    Wouters D; Zeerleder S
    Haematologica; 2015 Nov; 100(11):1388-95. PubMed ID: 26521297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.
    Berentsen S
    Semin Hematol; 2018 Jul; 55(3):141-149. PubMed ID: 30032751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Herbreteau L; Le Calloch R; Arnaud B; Cassou N; Rizcallah MJ; Hutin P; Le Clech L
    Ann Hematol; 2021 Aug; 100(8):2105-2106. PubMed ID: 34003325
    [No Abstract]   [Full Text] [Related]  

  • 10. In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Juskewitch JE; Murray JD; Norgan AP; Moldenhauer SK; Tauscher CD; Jacob EK; Murray DL
    Transfusion; 2021 Apr; 61(4):1302-1311. PubMed ID: 33502021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Complement in Autoimmune Hemolytic Anemia.
    Berentsen S
    Transfus Med Hemother; 2015 Sep; 42(5):303-10. PubMed ID: 26696798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for treatment of cold agglutinin disease.
    Gelbenegger G; Berentsen S; Jilma B
    Expert Opin Biol Ther; 2023 May; 23(5):395-406. PubMed ID: 37128907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cold agglutinin disease (CAD), paroxysmal cold hemoglobinuria (PCH) and intravascular hemolysis].
    Kozuru M; Kurata T
    Nihon Rinsho; 1979 Dec; 37(12):3953-60. PubMed ID: 395339
    [No Abstract]   [Full Text] [Related]  

  • 14. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.
    Berentsen S; Sundic T
    Biomed Res Int; 2015; 2015():363278. PubMed ID: 25705656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune haemolytic anaemias. V. studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease.
    Engelfriet CP; Von dem Borne AE; Beckers D; Reynierse E; Van Loghem JJ
    Clin Exp Immunol; 1972 Jun; 11(2):255-64. PubMed ID: 4114316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
    Berentsen S; Beiske K; Tjønnfjord GE
    Hematology; 2007 Oct; 12(5):361-70. PubMed ID: 17891600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct antiglobulin test reactive with complement only in warm type autoimmune hemolytic anemia.
    Shvidel L; Shtalrid M; Duek A; Haran M; Berrebi A; Sigler E
    Int J Lab Hematol; 2008 Dec; 30(6):494-8. PubMed ID: 18983301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
    Berentsen S
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cold haemolytic syndrome.
    Gertz MA
    Br J Haematol; 2007 Aug; 138(4):422-9. PubMed ID: 17561970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-directed therapy for cold agglutinin disease: sutimlimab.
    Broome CM
    Expert Rev Hematol; 2023; 16(7):479-494. PubMed ID: 37256550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.